Injection Onopac 260mg

Onopac 260mg Injection

Composition: Paclitaxel 260mg/46.5ml

Manufacturer: Medarmi Biopher Pvt. Ltd

Supplied by: Kadmed Pharma

Onopac 260mg Injection is a chemotherapy medication containing Paclitaxel, used to treat various types of cancer, including ovarian, breast, lung, pancreatic, and AIDS-related Kaposi’s sarcoma. Paclitaxel works by interfering with the growth and division of cancer cells, ultimately leading to cell death.

Indications:

– Ovarian cancer
– Breast cancer
– Non-small cell lung cancer
– Pancreatic cancer
– AIDS-related Kaposi’s sarcoma

Presentation:

– Injection: 260mg/46.5ml